Related references
Note: Only part of the references are listed.Adipokines and Cardiovascular Risk in Cushing's Syndrome
Elena Valassi et al.
NEUROENDOCRINOLOGY (2012)
Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study
D. J. F. Stuijver et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone
Phillip J. Monaghan et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
Medical Treatment of Cushing's Syndrome: Adrenal-Blocking Drugs and Ketaconazole
Richard A. Feelders et al.
NEUROENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pharmacological management of Cushing's syndrome: An update
Cuong Nguyen Dang et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Share Paper
